A federal plan to cut Medicare reimbursement rates for medical diagnostics as much as 91 percent sent the market value of Bay Area test developers plunging.
The Wall Street shakeout couples with investor concerns over potential regulation of drug prices, combining to whack the life sciences sector and send stocks as much as 40 percent lower on Monday alone.
Hey, check out all the research scientist jobs. Post your resume today!
